Please sign in to follow a disease.
No-Narcotic pain relief after hip surgery shows promise
NCT ID NCT05076110
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combination of non-narcotic pain relievers—ibuprofen, gabapentin, acetaminophen, and methocarbamol—after hip arthroscopy. 86 adults participated to see if this regimen could control pain without using opioids. The goal was to find a safer way to manage post-surgery pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a combination of ibuprofen, gabapentin, acetaminophen, and methocarbamol
- What this could lead to
- If successful, this could offer a way to manage pain after hip surgery without using narcotics, reducing the risk of addiction.
- What could go wrong
- This is a small, single-center study with 86 participants, so results may not apply to everyone. The regimen may not control pain as well as narcotics for some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
86 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN) Exclusion Criteria: * medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin. * Substantial alcohol or drug abuse. * History of narcotics within 6 months of surgery. * Pregnancy. * Renal impairment. * Peptic ulcer disease. * GI bleeding.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip arthroscopy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo clinic
Rochester, Minnesota, 55401, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which stitch heals hips better? a trial seeks answers
- Jumping and squatting after hip surgery: new study seeks clues for faster recovery
- Could a common Anti-Inflammatory replace opioids after hip surgery?
- Video game for the brain: could neurofeedback supercharge Post-Surgery recovery?
- Massive hip surgery showdown: preservation vs. replacement
- Hip surgery showdown: to stitch or not to stitch the capsule?